Multicenter evaluation of an intrapericardial left ventricular assist system

Area of Science:

• Cardiology
• Biomedical Engineering
• Clinical Trials

Background:

• Heart failure is a global epidemic with limited treatment options.
• Mechanical circulatory support, particularly rotary pump left ventricular assist devices, is emerging as a primary therapy for end-stage heart disease.
• These devices offer potential reductions in morbidity and mortality.

Purpose of the Study:

• To conduct an initial clinical evaluation of the novel HeartWare Ventricular Assist System.
• To assess the safety and efficacy of this device in heart failure patients.

Main Methods:

• A multicenter, prospective, nonrandomized single-arm clinical trial.
• Fifty patients with New York Heart Association functional class IV symptoms were supported by the HeartWare System for up to 180 days or until transplant, recovery, or death.
• Long-term follow-up for survivors was at least 2 years.

Main Results:

• Survival rates at 6, 12, and 24 months were 90%, 84%, and 79%, respectively.
• Significant improvements in quality of life and recognition memory were observed in survivors.
• The most common adverse events included infection and bleeding.

Conclusions:

• The HeartWare Ventricular Assist System provides safe and effective support for patients with end-stage heart failure.
• The device can lead to improved quality of life and neurocognitive function.
• This technology represents a viable option for mechanical circulatory support.